Submission Details
| 510(k) Number | K242728 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 10, 2024 |
| Decision Date | July 31, 2025 |
| Days to Decision | 324 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K242728 is an FDA 510(k) clearance for the BeneVision Central Monitoring System, a System, Network And Communication, Physiological Monitors (Class II — Special Controls, product code MSX), submitted by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on July 31, 2025, 324 days after receiving the submission on September 10, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2300.
| 510(k) Number | K242728 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 10, 2024 |
| Decision Date | July 31, 2025 |
| Days to Decision | 324 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | MSX — System, Network And Communication, Physiological Monitors |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2300 |